Hippocratic AI distribution flywheel

The real moat here is not just cheaper labor, it is distribution through trust. Each new agent adds another narrow clinical workflow that a health system can deploy without building it from scratch, which makes the platform more useful to buyers. That growing customer base then gives clinicians and developers a reason to build on Hippocratic first, because the platform already has certified deployment paths, customer access, and a revenue share model tied to real usage.

• The app store is designed to lower supply creation costs. Clinicians can prototype an agent in under 30 minutes, no coding is required, and creators keep 5% of base fees plus 70% of any premium rate. That turns specialist know how into a monetizable software asset, which is what pulls in more builders.
  1 businesswire 2 sacra
• Demand side pull comes from live health system deployments, not abstract developer interest. WellSpan put agents into daily operations for colorectal screening outreach and colonoscopy prep, while UHS used discharge follow up agents that contacted thousands of patients and earned a 9.0 out of 10 average rating, creating proof points for additional customers.
  3 globenewswire 4 hippocraticai
• The platform becomes harder to replicate as implementation partners and enterprise customers stack on top. KPMG is using Hippocratic to identify high pressure workflows across the care continuum and plan deployments globally, which widens the set of health systems that can adopt packaged agents and gives builders a larger downstream market.
  5 kpmg 6 hippocraticai

This is heading toward a healthcare specific agent marketplace where distribution, certification, and workflow depth matter more than the base model. If Hippocratic keeps adding customers, implementation partners, and specialty specific agents, it can become the default channel for patient facing clinical automation in the same way major software ecosystems became the default place to launch business apps.